You have 9 free searches left this month | for more free features.

growth hormone, liraglutide, AgRP

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Growth Hormone Deficiency, Healthy Trial in New York (growth hormone and lirglutide, growth hormone, liraglutide)

Not yet recruiting
  • Growth Hormone Deficiency
  • Healthy
  • growth hormone and lirglutide
  • +3 more
  • New York, New York
    Neuroendocrine Unit and Pituitary Center, Columbia University Ir
Dec 27, 2022

The AgRP and GH/IGF-1 Axis in Children

Not yet recruiting
  • Growth Hormone Deficiency
    • (no location specified)
    Dec 8, 2022

    A Prospective Study of Outcome After Therapy for Acromegaly

    Active, not recruiting
    • Acromegaly
    • Surgery for acromegaly
    • +3 more
    • New York, New York
      Neuroendocrine Unit; Columbia University Medical Center, 180 For
    Oct 24, 2022

    Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )

    Completed
    • Metabolism and Nutrition Disorder
    • Obesity
    • Santa Monica, California
    • +31 more
    Nov 18, 2022

    Taking Daily Growth Hormone Injections to Weekly Ngenla in Low

    Not yet recruiting
    • Pediatric Growth Hormone Deficiency
    • Sharps bin to collect used needles/injections
    • (no location specified)
    Nov 1, 2023

    Growth Hormone Treatment, Growth Hormone Deficiency, Concussion, Mild Trial (Growth Hormone, Placebo)

    Not yet recruiting
    • Growth Hormone Treatment
    • +3 more
    • Growth Hormone
    • Placebo
    • (no location specified)
    Dec 13, 2022

    Growth Hormone Deficiency Trial in New York (Blood draws, Growth hormone releasing hormone (GHRH) and arginine, Carotid

    Terminated
    • Growth Hormone Deficiency
    • Blood draws
    • +4 more
    • New York, New York
      Columbia University, College of Physicians and Surgeons
    Oct 24, 2022

    Healthy, Type 1 Diabetes Trial in Tartu (Placebo, Lixisenatide 10 micrograms (50 micrograms/ml in 3 ml) Pen Injector)

    Not yet recruiting
    • Healthy
    • Type 1 Diabetes
    • Placebo
    • Lixisenatide 10 micrograms (50 micrograms/ml in 3 ml) Pen Injector
    • Tartu, Estonia
      Tartu University Hospital
    Apr 7, 2023

    Quality of Life, Clinical Response and Safety of Daily and

    Recruiting
    • Growth Hormone Deficiency
    • Growth Hormone Treatment
    • Long-Acting Growth Hormone (LAGH)
    • Minneapolis, Minnesota
      University of Minnesota
    Sep 29, 2022

    Growth Disorders Trial in Washington (Somatropin)

    Enrolling by invitation
    • Growth Disorders
    • Washington, District of Columbia
      Children's National Hospital
    Aug 29, 2022

    Sogroya® in Short Stature Due to Growth Hormone Deficiency Where

    Recruiting
    • Growth Hormone Deficiency in Children
    • Tokyo, Japan
      Novo Nordisk Investigational Site
    Oct 25, 2023

    Breast Tumors Trial in Beijing, Nanjing, Changsha (Disitamab Vedotin, Toripalimab)

    Not yet recruiting
    • Breast Neoplasms
    • Beijing, Cancer Hospital Chinese Academy Of Medical Sciences, China
    • +2 more
    Oct 23, 2023

    Information Integrated Nurse-led Monitoring Clinic

    Active, not recruiting
    • Short Stature
    • Growth Hormone Treatment
    • integrated information and nurse led telephone clinic
    • Manchester, United Kingdom
      Indraneel Banerjee
    Jan 17, 2023

    Growth Hormone Deficiency Trial in Centennial (No intervention)

    Recruiting
    • Growth Hormone Deficiency
    • No intervention
    • Centennial, Colorado
      Ascendis Pharma Investigational Site
    Apr 18, 2023

    Obesity Trial in Ras al-Khaimah (POSE2.0 Endoscopic Gastric Remodeling, Liraglutide injection)

    Recruiting
    • Obesity
    • POSE2.0 Endoscopic Gastric Remodeling
    • Liraglutide injection
    • Ras al-Khaimah, United Arab Emirates
      Ibrahim Bin Hamad Obaidullah Hospital
    Jan 27, 2023

    Polycystic Ovary Trial in Bani Suwayf (liraglutide, Metformin)

    Not yet recruiting
    • Polycystic Ovary
    • Banī Suwayf, Beni Suef, Egypt
      Beni-suef university Hospital
    Jul 28, 2023

    Poor Ovarian Reserve Trial in Bani Suwayf (4 IU of recombinant GH (Somatotropin ))

    Recruiting
    • Poor Ovarian Reserve
    • 4 IU of recombinant GH (Somatotropin )
    • Banī Suwayf, Beni Suef, Egypt
      Beni-suef university
    Oct 27, 2022

    Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Worldwide (Samuraciclib, Elacestrant DiHCl)

    Recruiting
    • Metastatic Breast Cancer
    • +2 more
    • Orange City, Florida
    • +27 more
    Jul 19, 2023

    Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Ocala (Samuraciclib, Fulvestrant)

    Recruiting
    • Metastatic Breast Cancer
    • +2 more
    • Ocala, Florida
      Ocala Oncology Center PL DBA Florida Cancer Affiliates
    Jul 19, 2023

    Breast Cancer Trial (Trastuzumab Deruxtecan)

    Not yet recruiting
    • Breast Cancer
    • Trastuzumab Deruxtecan
    • (no location specified)
    Jul 10, 2023

    Effect of Exogenous Growth Hormone on Ocular Findings

    Recruiting
    • Precocious Puberty
    • +2 more
      • Isfahan, Iran, Islamic Republic of
      • +1 more
      Apr 15, 2022

      Ribociclib in Combination With Hormonal Therapy in HR+/HER2-

      Not yet recruiting
      • Breast Cancer
      • ribociclib
      • (no location specified)
      Oct 10, 2023

      Breast Cancer Trial in Worldwide (GDC-9545, Palbociclib, LHRH Agonist)

      Active, not recruiting
      • Breast Cancer
      • Aurora, Colorado
      • +23 more
      Jan 30, 2023

      Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7 Trial in Worldwide (drug, other, radiation)

      Active, not recruiting
      • Breast Adenocarcinoma
      • +6 more
      • Anniston, Alabama
      • +1230 more
      Jan 28, 2023

      Growth Hormone Deficiency Trial in Santiago (LUM-201)

      Recruiting
      • Growth Hormone Deficiency
      • Santiago, Chile
        Institute of Maternal and Child Research, University of Chile
      Jul 12, 2022